<p>This week on The Genetics Podcast, Patrick is joined by Leeland Ekstrom, CEO and co-founder of Nashville Bio. They discuss how Leeland went from being a consultant on a project for Vanderbilt University to a co-founder of a start-up and the unique aspects of NashBio’s clinical and genetic database.</p><p><strong>Show Notes: </strong></p><p><strong>0:00 </strong>Intro to The Genetics Podcast</p><p><strong>00:59</strong> Welcome to Leeland and the origin story of Nashville Bio</p><p><strong>05:13</strong> Process of setting up NashBio’s genome resource with 250K individuals</p><p><strong>11:52 </strong>How different pharmaceutical companies responded to NashBio’s database and its unique advantages compared to others</p><p><strong>17:50 </strong>Key priorities for applications of the resource beyond target discovery</p><p><strong>20:19 </strong>The process of selecting additional gaps that NashBio’s services can fill versus letting others fill them</p><p><strong>25:02 </strong>Advantages at Vanderbilt Medical Center that facilitated the project and how it can be replicated at other centers</p><p><strong>30:32 </strong>Immediate and long-term impacts of current NIH funding cuts on biotech and academia</p><p><strong>36:43 </strong>NashBio’s current major focuses and future goals</p><p><strong>39:20 </strong>Closing remarks</p><p><strong>Find out more</strong></p><ul><li><p>NashBio (<a href="https://nashbio.com/"><u>https://nashbio.com/</u></a>)</p></li><li><p>Press release: Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery (<a href="https://www.illumina.com/company/news-center/press-releases/press-release-details.html?newsid=b4b0c901-f8a2-4802-a4ef-b81167e24cfe"><u>https://www.illumina.com/company/news-center/press-releases/press-release-details.html?newsid=b4b0c901-f8a2-4802-a4ef-b81167e24cfe</u></a>) </p></li></ul><p>Please consider rating and reviewing us on your chosen podcast listening platform! </p><p><a href="https://drive.google.com/file/d/1Bp2_wVNSzntTs_zuoizU8bX1dvao4jfj/view?usp=share_link"><u>https://drive.google.com/file/d/1Bp2_wVNSzntTs_zuoizU8bX1dvao4jfj/view?usp=share_link</u></a></p><p><br></p>

The Genetics Podcast

Sano Genetics

EP 180: From a consulting project to a biotech start-up with Leeland Ekstrom of Nashville Bio

MAR 27, 202541 MIN
The Genetics Podcast

EP 180: From a consulting project to a biotech start-up with Leeland Ekstrom of Nashville Bio

MAR 27, 202541 MIN

Description

<p>This week on The Genetics Podcast, Patrick is joined by Leeland Ekstrom, CEO and co-founder of Nashville Bio. They discuss how Leeland went from being a consultant on a project for Vanderbilt University to a co-founder of a start-up and the unique aspects of NashBio’s clinical and genetic database.</p><p><strong>Show Notes: </strong></p><p><strong>0:00 </strong>Intro to The Genetics Podcast</p><p><strong>00:59</strong> Welcome to Leeland and the origin story of Nashville Bio</p><p><strong>05:13</strong> Process of setting up NashBio’s genome resource with 250K individuals</p><p><strong>11:52 </strong>How different pharmaceutical companies responded to NashBio’s database and its unique advantages compared to others</p><p><strong>17:50 </strong>Key priorities for applications of the resource beyond target discovery</p><p><strong>20:19 </strong>The process of selecting additional gaps that NashBio’s services can fill versus letting others fill them</p><p><strong>25:02 </strong>Advantages at Vanderbilt Medical Center that facilitated the project and how it can be replicated at other centers</p><p><strong>30:32 </strong>Immediate and long-term impacts of current NIH funding cuts on biotech and academia</p><p><strong>36:43 </strong>NashBio’s current major focuses and future goals</p><p><strong>39:20 </strong>Closing remarks</p><p><strong>Find out more</strong></p><ul><li><p>NashBio (<a href="https://nashbio.com/"><u>https://nashbio.com/</u></a>)</p></li><li><p>Press release: Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery (<a href="https://www.illumina.com/company/news-center/press-releases/press-release-details.html?newsid=b4b0c901-f8a2-4802-a4ef-b81167e24cfe"><u>https://www.illumina.com/company/news-center/press-releases/press-release-details.html?newsid=b4b0c901-f8a2-4802-a4ef-b81167e24cfe</u></a>) </p></li></ul><p>Please consider rating and reviewing us on your chosen podcast listening platform! </p><p><a href="https://drive.google.com/file/d/1Bp2_wVNSzntTs_zuoizU8bX1dvao4jfj/view?usp=share_link"><u>https://drive.google.com/file/d/1Bp2_wVNSzntTs_zuoizU8bX1dvao4jfj/view?usp=share_link</u></a></p><p><br></p>